Skip to content

Prevention of Acute Mountain Sickness by Intermittent Hypoxia

Prevention of Acute Mountain Sickness by Sleeping at Simulated Altitude (Normobaric Hypoxia)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00559832
Enrollment
75
Registered
2007-11-16
Start date
2006-03-31
Completion date
2007-07-31
Last updated
2007-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Mountain Sickness

Keywords

acute mountain sickness, intermittent hypoxia, acclimatization

Brief summary

Acclimatization by mountaineering prior to high altitude sojourns have shown to be effective in prevention of acute mountain sickness (AMS). The aim of this study is to investigate whether intermittent exposure to normobaric hypoxia during sleep is also effective to prevent AMS.

Interventions

Sleeping in normobaric hypoxia for 14 nights at altitudes from 2500 - 3300 m prior to one night at 4500 m

Sponsors

Heidelberg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy

Exclusion criteria

* Altitude exposure above 2000 m 8 weeks prior or during the study

Design outcomes

Primary

MeasureTime frame
incidence of acute mountain sicknessduring one night at 4500 m

Secondary

MeasureTime frame
Sleep qualityduring one night at altitude
ventilatory acclimatizationduring one night at altitude

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026